Sign In to Follow Application
View All Documents & Correspondence

Composition Comprising Plant Extracts And Uses

Abstract: The present disclosure provides compositions comprising plant extracts, which in particular w/w ratios, and weight concentrations exhibits enhanced epithelial wound closure. Also provided are methods of preparing said compositions and uses.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
24 February 2016
Publication Number
34/2017
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
lsmds@lakshmisri.com
Parent Application

Applicants

ITC LIMITED
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058, India

Inventors

1. HASSAN, Sarah
ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058
2. KHAN, Manisha
ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058
3. PHULERA, Sumit
ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058

Specification

Claims:1. A composition comprising:
a. Schizandra chinensis fruit extract; and
b. at least one extract selected from the group consisting of:
i. Ficus carica fruit extract;
ii. Callendulla officinalis flower extract;
iii. Nymphaea alba flower extract; and
iv. combinations thereof,
wherein Schizandra chinensis fruit extract to at least one extract w/w ratio is in the range of 1:0.3-1:0.0033.
2. The composition as claimed in claim 1, further comprising suitable carriers, diluents, and excipients.
3. The composition as claimed in any of the claims 1-2, wherein Schizandra chinensis fruit extract weight concentration in said composition is in the range of 500-1500 ppm, and at least one extract weight concentration in said composition is in the range of 5-150 ppm.
4. The composition as claimed in any of the claims 1-2, wherein Schizandra chinensis fruit extract to Ficus carica fruit extract w/w ratio in said composition is in the range of 1:0.03-1:0.0033.
5. The composition as claimed in claim 4, wherein Schizandra chinensis fruit extract weight concentration in said composition is in the range of 500-1500 ppm, and Ficus carica fruit extract weight concentration in said composition is in the range of 5-15 ppm.
6. The composition as claimed in any of the claims 1-2, wherein Schizandra chinensis fruit extract to Callendulla officinalis flower extract w/w ratio in said composition is in the range of 1:0.3-1:0.033.
7. The composition as claimed in claim 6, wherein Schizandra chinensis fruit extract weight concentration in said composition is in the range of 500-1500 ppm, and Callendulla officinalis flower extract weight concentration in said composition is in the range of 50-150 ppm.
8. The composition as claimed in any of the claims 1-2, wherein Schizandra chinensis fruit extract to Nymphaea alba flower extract w/w ratio in said composition is in the range of 1:0.3-1:0.33.
9. The composition as claimed in claim 8, wherein Schizandra chinensis fruit extract weight concentration in said composition is in the range of 500-1500 ppm, and Nymphaea alba flower extract weight concentration in said composition is in the range of 50-150 ppm.
10. A method of preparing a composition as claimed in any of the claims 1-9.
11. A method of epidermal wound closure, said method comprising:
a. obtaining a composition as claimed in any of the claims 1-9; and
b. contacting said composition with site of epidermal wound,
wherein said method promotes epidermal wound closure.
, Description:As Attached

Documents

Application Documents

# Name Date
1 Form 5 [24-02-2016(online)].pdf 2016-02-24
2 Form 3 [24-02-2016(online)].pdf 2016-02-24
3 Drawing [24-02-2016(online)].pdf 2016-02-24
4 Description(Complete) [24-02-2016(online)].pdf 2016-02-24
5 Other Patent Document [05-07-2016(online)].pdf 2016-07-05
6 Form 26 [05-07-2016(online)].pdf 2016-07-05
7 201641006385-Power of Attorney-110716.pdf 2016-07-29
8 201641006385-Form 1-110716.pdf 2016-07-29
9 201641006385-Correspondence-F1-PA-110716.pdf 2016-07-29